carlisle & Associates
generic drug updates News contact carlisle medical
generic drug updates
Generic Luxiq® Launches
Released: 01/21/2013
By: Mike Partridge, RPh

On January 15, 2013, Perrigo received final FDA approval for and commenced shipping the generic equivalent for GlaxoSmithKlines’s branded product, Luxiq® (betamethasone valerate) foam. Luxiq® had estimated total U.S. annual sales of approximately $30 million.

Betamethasone valerate foam is used to treat skin conditions of the scalp (such as psoriasis, seborrhea). Betamethasone valerate foam works by decreasing the swelling (inflammation), itching, and redness.

Company News Releases
Generic Drug Updates
Newsletter Subscription
Newsletter Login
© Copyright 2019 Carlisle Medical, Inc.
Twitter Twitter Twitter Twitter
disclaimer site map disclaimer